Small-vessel vasculitis after ST-segment elevation myocardial infarction
Abstract: We report a case of cutaneous small-vessel vasculitis in a patient treated with clopidogrel after an ST-segment elevation myocardial infarction and with amiodarone caused by persistent atrial fibrillation 6 weeks before. (Level of Difficulty: Intermediate.)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
JACC: case reports. - 4, 15 (2022) , 967-971, ISSN: 2666-0849
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2022
- Urheber
- DOI
-
10.1016/j.jaccas.2022.05.008
- URN
-
urn:nbn:de:bsz:25-freidok-2290706
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lehr, Saskia
- Meiß, Frank
- Kiritsi, Dimitra
- Tsakiris, Leonidas
- Universität
Entstanden
- 2022
Ähnliche Objekte (12)
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Untersuchungen zum Einfluß des arteriellen Leberblutflusses und von Sauerstoff auf die Leberfunktion bei Patienten mit Zirrhose
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Hemidesmosomal reactivity and treatment recommendations in immune checkpoint inhibitor-induced bullous pemphigoid - a retrospective, monocentric study
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Real world outcomes using PD‐1 antibodies and BRAF+ MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): update 2021
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – an evaluation of the multicenter prospective skin cancer registry ADOREG
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Untersuchungen zum Einfluß des arteriellen Leberblutflusses und von Sauerstoff auf die Leberfunktion bei Patienten mit Zirrhose
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Hemidesmosomal reactivity and treatment recommendations in immune checkpoint inhibitor-induced bullous pemphigoid - a retrospective, monocentric study
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Real world outcomes using PD‐1 antibodies and BRAF+ MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): update 2021
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – an evaluation of the multicenter prospective skin cancer registry ADOREG
IL17 inhibition for psoriasis vulgaris and arthritis results in clinical and serological remission of coexistent pemphigus foliaceus: letter to the editor
Untersuchungen zum Einfluß des arteriellen Leberblutflusses und von Sauerstoff auf die Leberfunktion bei Patienten mit Zirrhose
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Hemidesmosomal reactivity and treatment recommendations in immune checkpoint inhibitor-induced bullous pemphigoid - a retrospective, monocentric study
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Real world outcomes using PD‐1 antibodies and BRAF+ MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
S2k‐Guidelines – Cutaneous lymphomas (ICD10 C82 ‐ C86): update 2021